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Abstract 
One of the leading challenges in public health today is moving forward as one whether we are part of 
academia, a clinical health setting, or a public health department, in order to improve health outcomes. 
Right now in the United States, the leading causes of death are caused from diseases that are 
preventable. We also face a steady rise in health inequalities among those citizens with a lower 
socioeconomic status. Director of the CDC, Thomas Friedan addressed the Keeneland conference 
audience on the impact that public health initiatives have had on the health of our nation. Public health 
interventions have a potential impact in all levels and the challenge is to identify areas where we can work 
systematically to improve health outcomes. Six key areas for potential impacts are smoking, obesity, 
health care associated infections, HIV, teen pregnancy, motor vehicle accidents. Major initiatives that 
need to be undertaken are heart attack and stroke prevention, electronic health records, and clinical 
innovations that involve improving quality of care and reducing prices. It is also vital that we come up with 
ways to bridge the gaps in program implementation. 
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We think about the value of research in changing people’s lives around the world and 
around the state.  I want you to picture in your mind a person who you know who has 
had a heart attack or a stroke and a person who you know who has had cancer.  At least 
half of all of the heart attacks and strokes and cancers in this country and in this world 
could be prevented with easy, inexpensive interventions that are available to us today.  
So at least one of those two people who you pictured didn’t have to go through that.  
The biggest challenge for health research, for public health, and for clinical medicine 
moving forward is how to be as one program focused on improving health status 
whether we do that from the public health department, from the university, from the 
clinical provider, from the community health center, from the pharmacy, from the 
school, from the workplace.  That is our biggest challenge in health today, and health is 
our biggest challenge in our country today.  So that is our number one challenge.   
 
Falling Behind  
 
Health services research can be very important in helping us to address that challenge.  
Now, what this slide shows* is what I just said.  If you look at three of the leading causes 
of death in the U.S.—cardiovascular disease, cancer, and unintentional injuries—at least 
half (that’s a rough estimate), but at least half of each of those conditions are 
preventable with current technologies.  If you look at how we’re doing compared to the 
rest of the world, this is quite interesting because if you just focus for a bit on the blue 
bars, that was just 15 years ago.  We were better than a couple; not much worse than 
many.  Over the past 15 years, the world has kind of left us in the dust.  They have 
significantly reduced conditions that are preventable through health care, death from 
conditions preventable through health care, and we have not.  The result of that is that 
we are making much slower progress than other countries, and the result is that chronic 
diseases are the leading cause of death and disability in the U.S.:  1.7 million deaths per 
year, half of all Americans have one or more chronic conditions, and more than three-
quarters of all health care costs.  What you see is that this is not sustainable in our 
society.  The number of Medicare beneficiaries continues to increase, and the number 
of workers per beneficiary continues to decrease.  Medicare is dealing with the results 
of failure to prevent and effectively treat high blood pressure, high cholesterol, heart 
disease, diabetes, arthritis, and more.   
 
As NACCHO has said, not only is our health status poor, but our inequalities are very 
large.  Our inequalities in health status are large, persistent, and increasing.  Poverty, 
income, wealth inequality, poor quality of life, racism, sex discrimination, and low 
socioeconomic conditions are the major risk factors for ill health and health inequalities.  
African Americans have a lower life expectancy than white Americans by 4 to 7 years for 
females and males, and heart disease is the leading single cause of that difference in life 
expectancy, with cancer number two.   
 
                                                          
* see: http://www.publichealthsystems.org/uploads/docs/Frieden_KC2012.pdf for slides 
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The factors that affect health are at the base of the socioeconomic factors that 
determine the structure of our society:  poverty, education, housing, inequality.  One 
level above that are things that change the context and make the default decision the 
healthy decision, whether that is clean water or iodized salt or smoke-free air or zero 
grams trans fat or tobacco taxes that are high.  This makes the default decision healthy.  
One level above that are long-lasting preventive interventions like immunizations or 
brief intervention for problem drinking or colonoscopy or tobacco cessation.  One level 
above that are clinical interventions, things that require the health care system to work 
day in and day out all year long:  treatment of high blood pressure, high cholesterol, 
diabetes.  At the top level is counseling and education, encouraging people to eat 
healthy, be physically active.  This is not to say that we should only do one or another 
level, although the impact of these interventions tends to be largest at the bottom and 
smallest at the top.  But for any health program, there are interventions that have the 
potential to make a difference at every level.  Our challenge is to identify the areas 
where we can make a difference and then systematically and objectively work to 
improve health in those particular areas.   
 
Six Key Areas of Impact  
 
At the Centers for Disease Control and Prevention, we identified 6 key areas where we 
think we can make a really big difference, and I will go through those one by one.   
1. Tobacco use remains the leading preventable cause of death in the U.S.  Tobacco 
will kill more than 1000 people today and every day this year.  It will cost our 
health care system around $100 billion, and it will expose more than half of our 
children to secondhand smoke, and yet we know what to do.  We are making 
progress.  Porportionally, fewer people smoke now than have ever smoked 
before.  Smoke-free laws are expanding.  We began running Tips From Former 
Smokers, a hard-hitting ad campaign on tobacco.  How many people in this room 
have seen the ad campaign?  We estimate that by the time the 12-week 
campaign finishes, 90% of smokers will have seen one ad at least 10 times.  This 
is the first national advertising campaign against tobacco paid for by any part of 
the federal government. The budget for this campaign is less than what the 
tobacco industry pays in two days for marketing and promotion, so we are 
getting outspent for our entire year in two days of tobacco industry marketing 
and promotion.  And yet, this campaign will be very successful because we have 
truth on our side and we have real people’s stories.  I heard earlier from officials 
here in Kentucky that calls to the quit line in Kentucky have increased fivefold 
since the ads began running, and we did not put the quit line number on most 
ads because we were afraid of overwhelming the quit lines.  So this is an 
example of the kind of big difference that can be made.  You see here graphs of 
the California experience and the New York City experience where smoking has 
declined by more than a third, teen smoking by more than half.  Teen smoking in 
the leading jurisdictions in the U.S. is now at 7%, one-third the national average 
of about 20%.  So progress is definitely possible.   
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2. Nutrition, obesity, food safety, and physical activity are also critically important.  
A huge burden.  Someone who is obese costs the health care system on average 
$1700 more per year to care for.  One in 6 people in the U.S. gets sick every year 
from food-borne illness, and food-borne illness costs a lot.  A single, fatal case of 
E. coli O157 can cost $7 million.  We have made progress.  In some age groups, 
we have seen declines in obesity.  New York City, through a comprehensive 
approach, has rigorously documented in hundreds of thousands of school kids a 
decrease in obesity of 6%, and a decrease of 10% in the younger age groups.  We 
are not sure what caused that, but we are seeing progress in various jurisdictions 
around the country.  E. coli O157 infections decreased by half in the past 14 
years through a collaboration with industry and public health.  
3. Health care-associated infections affect 1 in 20 hospitalized patients.  They cost 
about $30 billion a year.  If you look at just one particular problem, Clostridium 
difficile, which we recently published an update on, nearly all infections are from 
the health care setting, and about 14,000 Americans die each year as a result of 
complications of C. difficile, and yet we are seeing real progress with steady 
declines in central line infections.  So again, a winnable battle, an area where we 
can make a difference.   
4. Motor vehicle injuries, 33,000 deaths a year, 3 million emergency department 
visits a year, the number one cause of injury death, the number one cause of 
death in Americans age 1 to 44 and $100 billion in health care and economic 
costs, but we have made progress.  Nearly a 25% decline over the past few years 
in motor vehicle fatalities through a wide variety of efforts, including expansion 
of ignition interlock devices and expansion of graduated drivers’ licenses, making 
it safer for kids to learn to drive without endangering themselves, their friends, 
and other drivers and pedestrians.   
5. Teen pregnancy.  One thousand teens give birth every day in this country.  One 
out of 11 new mothers is a teen.  Our rate of teen pregnancy is 9 times higher 
than the rate of other countries, and the cost to taxpayers is about $9 billion 
every year.  More than that, teen pregnancy condemns the next generation to 
not living up to their full potential and often represents the intergenerational 
transmission of poverty.  We are seeing progress; not nearly enough, but 
progress with a 17% drop in teen pregnancy in recent years.  These are areas 
where we are making progress, and we can make much more.   
6. HIV.  There are 1.2 million people living with HIV, and 1 in 5 of them do not know 
they are infected.  Only about 1 in 4, 28%, of people with HIV have their viral 
load suppressed.  That means that nearly 3 out of 4 are not getting effective 
treatment, and the virus is raging through their body, destroying their immune 
system, increasing their risk of cancer, and increasing their risk of infecting their 
partners, their families, and their communities.  The lifetime cost of caring for 1 
person with HIV is $400,000.  You can buy a lot of condoms to prevent HIV for 
$400,000.  We are making some progress - 11 million more Americans know 
their status than knew it just a few years ago, and we need to make even more 
progress helping people learn their status and get into care and stay in care.   
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Major Initiatives 
 
Heart disease and stroke are leading killers in the U.S.  There are two million heart 
attacks and strokes per year in this country, 800,000 deaths per year from heart attack 
and stroke, and 1 in 3 deaths is from heart attack or stroke.  Many of them are in 
younger individuals, and the conditions are costly, about $444 billion a year in health 
care and economic costs.  There is a lot that we can do to reduce cardiovascular disease, 
and that is why last year, in conjunction with the Center for Medicare and Medicaid 
Services, we launched the Million Hearts campaign.  We think we can prevent a million 
heart attacks and strokes in the next five years.  With  focused interventions we can do, 
on the one hand, is to  reduce the need for care through tobacco control, improvements 
in diet and nutrition such as the elimination of trans fat and reduction of sodium, and on 
the other, improve the care of people who are in need of care for high blood pressure 
and high cholesterol.  The several ways we have seen improved clinical care involve first 
and foremost looking at the numbers—getting everyone to focus on key outcome 
indicators.  What proportion of your patients have their blood pressure under control?  
We want every doctor, nurse practitioner, advanced practice nurse in America to know 
the answer to that question, whether they are an obstetrician, an orthopedist, or a 
primary care practitioner. That’s because right now, nationally, about 46% of Americans 
have their blood pressure under control.  Even for people in care, it is not much over 
60%.  But the best-performing health systems can get it up to 85% to 90%.  That 
difference is the difference between two million heart attacks and strokes a year and 
one and a half million heart attacks and strokes a year.  It is half a million Americans if 
you think back to that person you thought of at the very beginning of my talk.   
 
The second major initiative in clinical care is health information technology.  We are still 
in the Dark Ages, but we are rapidly emerging from them.  We are rapidly able to 
increase the availability of information before the patient’s visit, during the visit, and 
after the visit, not just for the doctor but for the entire health care team that has a role 
in patient care. We need to free that information.  As patients, why shouldn’t you own 
your health care data?   
 
And third, clinical innovations.  We know that there is only one solution to the following 
problem:how do you improve the quality of care, reduce expenditures, and preserve 
employment?  There is only one answer to that challenge.  You use a broader health 
care team where every member of the team is used to their fullest potential - to the 
limit of their license so they are practicing at the top of their competencies, not at the 
bottom. You have the physician as quarterback, point guard if you will since we are in 
Kentucky, and you make sure that there is optimal use of all members of the team.  We 
think that with this focus, we can reduce the number of people who smoke by four 
million and increase by 10 million the number of Americans whose blood pressure is 
under control.  Those are measurable numbers that are going to require laser-like focus.  
Most of the work in tobacco control will be done in communities.  Most of the work of 
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hypertension control will be done in clinical settings.  In tobacco control, we have things 
like hard-hitting ads, tobacco pricing, smoke-free air laws, and comprehensive 
programs.  They work.  Communities that implement them see their health care costs 
fall.  They see their smoking rates fall.  In the clinical sphere, we have blood pressure 
control and the potential to make a huge difference with reducing strokes, heart 
attacks, dialysis, kidney failure, eye problems, and a host of other health problems that 
come from high blood pressure.   
 
I also want to mention the epidemic of prescription drug overdose.  Prescription opioids 
now kill more people than heroin and cocaine combined, 15,000 people a year.  There 
has been a fourfold rise in the number of deaths in the past 10 years that mirrors an 
increase in the sales of these drugs.  In fact, enough opiates are prescribed each year to 
give every adult in America opiates every four hours around the clock for a month.  This 
is a major problem.  We think we can do a lot about it.  It won’t be easy, but it is 
possible to improve clinical practice; increase access to substance-abuse treatment; 
strengthen prescription drug-monitoring programs, which your congressman Hal Rogers 
has been instrumental in helping to create across the country; implement patient 
review and restriction programs; leverage insurer and pharmacy benefit managers and 
enforce laws, policies, and regulations to make a big difference in terms of both patients 
and providers. You have those who are appropriately using, and we need to ensure 
palliation and appropriate care for people, for example, with severe cancer pain.  You 
have a second group of patients or physicians who may simply lack adequate training 
and information and be prescribing inappropriately or demanding inappropriately.  A 
very interesting article last month in the Archives of Internal Medicine looked at patient 
satisfaction and patient outcomes.1 More satisfied patients used more health care, used 
less emergency department visits, and died younger.  It is not always the best thing to 
give patients everything they ask for, particularly if those are addictive substances.  And 
then there are a very small number of patients and a very small number of doctors who 
are breaking the law and are doing this for profit and essentially are drug pushers.  For 
that, you need the appropriate law enforcement response.  Hal Rogers has been a real 
leader in the fight against prescription drug overdose.  He rang the alarm early, and he 
has been a leader in helping to get programs up and running around the country.  We 
now need to optimize them, implement them, and ensure that we can make them 
effective at confronting this epidemic.   
 
Prevention  
 
The failure of prevention costs money.  As I said earlier, someone who has obesity costs 
about $1700 more to care for per year.  A smoker costs about $2600 more to care for 
per year.  Someone with diabetes costs about $7400 more to care for every year for the 
rest of their life.† There are scalable interventions, and one word I want you to take 
away from this conference is scalability.  Having an intervention that works great in a 
                                                          
†Corrected figures should be: $1400, $2000, and $6600, respectively.  
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small group but is never going to get scaled up means not having an intervention that is 
going to do the kind of good it could do.  The diabetes prevention program can reduce 
the risk of progression from pre-diabetes to diabetes by nearly 60%.  Working with the 
Y, we have been able to drive down the cost from $2000 to $400 to $500.  If you 
compare that with the $7000+ cost of diabetes care, you realize that this can be a cost-
saving intervention.  In fact, nationwide implementation of this would break even in a 
few years and provide billions of dollars of health care savings soon after that.   
 
Just to give an example from the past, let’s look at fluoridation. Fluoridation reduces 
dental caries substantially.  It saves about $20 for every one dollar spent and is highly 
effective to reduce costs.  Folic acid is another area where there has been real progress, 
more than a one-third reduction in neural tube defects, preventing an estimated 10,000 
children born with neural tube defects and saving more than $400 million in health care 
costs alone each year.  We have more to do with neural tube defect prevention, 
particularly among Hispanic women, and we are working with a company that has just 
submitted its proposal to the FDA, to fortify corn masa flour, which is more commonly 
used in Mexican American communities and will result in a further decline in neural 
tube defects in that population.   
 
We need public health systems and services research.  Prevention can improve health, 
reduce disease, and save money.  We need to identify and document cost reductions, 
and we need to identify how we can deliver the strategies that we identify at the right 
time to the populations most in need in the right way every day year round.  The 
challenge is to identify the scalable interventions and then scale them up.  Doing that 
will require establishing feedback loops—figuring out what works, figuring out if we are 
going to scale, if we do have fidelity to the model, if we are achieving the impact we 
anticipated.   
 
I give the example of my experience as a health commissioner in a large city where we 
implemented tobacco control interventions.  We increased the tobacco tax, and 
smoking went down.  We implemented the smoke-free air act, and smoking went down.  
We thought our job was done, but then smoking didn’t go down anymore.  We had a 
stall.  So we said, “What else can we do?”  We ran hard-hitting ads, and again we saw a 
dramatic decline in smoking.  If we had not had that feedback loop, we would not have 
known we needed to do something different.  We would not have achieved the results 
we did.  When we were criticized for spending that kind of money on hard-hitting ads, 
we would not have been able to defend them, but I was able because of the information 
systems that we had in place.  I was able to say under oath I was confident the ads we 
were running were saving at least 1500 lives for every million dollars we spent.  I think 
the life of one of our fellow citizens is certainly worth the modest investment that that 
represents.   
 
So bridging the implementation gap is the challenge for health services research and for 
public health research.  We have knowledge and technologies—things that we know 
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work—and we have the ability to implement, but what we all too often lack is the 
connection between those two things.  We have an implementation gap.  The gap 
between what we know and what we wish we knew is huge, but it is much smaller than 
the gap between what we know and what we do.  That is the challenge of all of us 
working in implementation research, how systems research and public health 
implementation, because ultimately there should be no gap between program and 
analysis.  It is not a question of analyzing over here and running a program over here.  A 
well-run program must have an in-built feedback loop to figure out if it is working so we 
can defend and extend programs that work and fix them if they are not.   
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